Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 17.99% is 42% below its 5-year average of 31.25%, near the low end of its 5-year range (17.99%–35.81%).
As of the fiscal period ended Friday, June 26, 2026. 33.18% below its 12-month average of 26.92%.
Reported quarterly EBITDA margin; no daily interpolation.
EBITDA MARGIN
17.99%
EBITDA MARGIN AVG TTM
26.92%
EBITDA MARGIN AVG 3Y
30.18%
EBITDA MARGIN AVG 5Y
31.91%
EBITDA MARGIN AVG 10Y
28.13%
EBITDA MARGIN AVG 15Y
25.99%
EBITDA MARGIN AVG 20Y
24.07%
CURRENT VS TTM AVG
-33.18%
CURRENT VS 3Y AVG
-40.40%
CURRENT VS 5Y AVG
-43.63%
CURRENT VS 10Y AVG
-36.05%
CURRENT VS 15Y AVG
-30.78%
CURRENT VS 20Y AVG
-25.25%
Danaher Corporation
Market Cap
$137.13B
EBITDA Margin
17.99%
TTM Avg
26.92%
3Y Avg
30.18%
5Y Avg
31.91%
Market Cap
$133.37B
EBITDA Margin
36.80%
TTM Avg
38.33%
3Y Avg
39.88%
5Y Avg
39.69%
Market Cap
$124.86B
EBITDA Margin
24.22%
TTM Avg
25.63%
3Y Avg
25.70%
5Y Avg
26.23%
Market Cap
$124.82B
EBITDA Margin
35.99%
TTM Avg
34.83%
3Y Avg
32.83%
5Y Avg
33.22%
Market Cap
$121.09B
EBITDA Margin
41.14%
TTM Avg
20.45%
3Y Avg
32.86%
5Y Avg
36.27%
Market Cap
$161.66B
EBITDA Margin
49.12%
TTM Avg
32.26%
3Y Avg
34.27%
5Y Avg
33.90%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Danaher Corporation (DHR) | $137.13B | 17.99% | 26.92% | 30.18% | 31.91% |
| Bristol-Myers Squibb Company (BMY)vs › | $133.37B | 36.80% | 38.33% | 39.88% | 39.69% |
| CVS Health Corp. (CVS)vs › | $133.25B | 3.73% | 3.63% | 4.02% | 4.83% |
| Pfizer Inc. (PFE)vs › | $142.54B | 32.51% | 34.72% | 32.84% | 32.73% |
| AstraZeneca PLC (AZN)vs › | $131.47B | 33.16% | 30.52% | 27.50% | 25.68% |
| Stryker Corporation (SYK)vs › | $124.86B | 24.22% | 25.63% | 25.70% | 26.23% |
| Intuitive Surgical, Inc. (ISRG)vs › | $124.82B | 35.99% | 34.83% | 32.83% | 33.22% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $121.09B | 41.14% | 20.45% | 32.86% | 36.27% |
| Gilead Sciences, Inc. (GILD)vs › | $161.66B | 49.12% | 32.26% | 34.27% | 33.90% |
| Medtronic plc (MDT)vs › | $109.30B | 25.92% | 26.11% | 25.62% | 25.51% |
Gross Margin
58.5%
EBITDA Margin
18.0%
Operating Margin
20.4%
Net Margin
15.9%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-26 | 17.99% |
| 2026-03-27 | 25.83% |
| 2025-12-31 | 31.08% |
| 2025-09-26 | 29.34% |
| 2025-06-27 | 30.37% |
| 2025-03-28 | 32.49% |
| 2024-12-31 | 35.81% |
| 2024-09-27 | 26.72% |
| 2024-06-28 | 30.44% |
| 2024-03-29 | 32.75% |
| 2023-12-31 | 29.77% |
| 2023-09-29 | 29.77% |
| 2023-06-30 | 27.82% |
| 2023-03-31 | 34.49% |
| 2022-12-31 | 34.65% |
| 2022-09-30 | 33.34% |
| 2022-07-01 | 35.57% |
| 2022-04-01 | 35.60% |
| 2021-12-31 | 33.64% |
| 2021-10-01 | 33.73% |
| 2021-07-02 | 35.05% |
| 2021-04-02 | 36.59% |
| 2020-12-31 | 31.21% |
| 2020-10-02 | 27.08% |
| 2020-07-03 | 24.95% |
| 2020-04-03 | 23.10% |
| 2019-12-31 | 23.92% |
| 2019-09-27 | 24.48% |
| 2019-06-28 | 24.97% |
| 2019-03-29 | 24.07% |
| 2018-12-31 | 23.11% |
| 2018-09-28 | 23.74% |
| 2018-06-29 | 24.43% |
| 2018-03-30 | 22.66% |
| 2017-12-31 | 25.98% |
| 2017-09-29 | 23.64% |
| 2017-06-30 | 23.56% |
| 2017-03-31 | 22.10% |
| 2016-12-31 | 22.56% |
| 2016-09-30 | 21.56% |
| 2016-07-01 | 23.43% |
| 2016-04-01 | 22.13% |
| 2015-12-31 | 21.99% |
| 2015-10-02 | 20.73% |
| 2015-07-03 | 23.00% |
| 2015-04-03 | 20.96% |
| 2014-12-31 | 20.77% |
| 2014-09-26 | 22.72% |
| 2014-06-27 | 22.66% |
| 2014-03-28 | 21.74% |
| 2013-12-31 | 21.29% |
| 2013-09-27 | 22.22% |
| 2013-06-28 | 22.44% |
| 2013-03-29 | 21.32% |
| 2012-12-31 | 21.76% |
| 2012-09-28 | 21.89% |
| 2012-06-29 | 22.37% |
| 2012-03-30 | 21.71% |
| 2011-12-31 | 20.94% |
| 2011-09-30 | 19.14% |
| 2011-07-01 | 20.11% |
| 2011-04-01 | 20.79% |
| 2010-12-31 | 20.30% |
| 2010-10-01 | 21.00% |
| 2010-07-02 | 19.12% |
| 2010-04-02 | 17.07% |
| 2009-12-31 | 15.41% |
| 2009-10-02 | 20.00% |
| 2009-07-03 | 16.08% |
| 2009-04-03 | 16.02% |
| 2008-12-31 | 15.99% |
| 2008-09-26 | 18.91% |
| 2008-06-27 | 18.09% |
| 2008-03-28 | 16.52% |
| 2007-12-31 | 17.28% |
| 2007-09-28 | 19.26% |
| 2007-06-29 | 19.16% |
| 2007-03-30 | 17.14% |
| 2006-12-31 | 19.20% |
| 2006-09-29 | 18.33% |
| 2006-06-30 | 18.44% |
| 2006-03-31 | 16.02% |
| 2005-12-31 | 17.47% |
| 2005-09-30 | 18.47% |
| 2005-07-01 | 18.95% |
| 2005-04-01 | 17.39% |
| 2004-12-31 | 17.93% |
| 2004-10-01 | 19.08% |
| 2004-07-02 | 19.15% |
| 2004-04-02 | 17.03% |
| 2003-12-31 | 19.69% |
| 2003-09-26 | 18.97% |
| 2003-06-27 | 18.11% |
| 2003-03-28 | 16.92% |
| 2002-12-31 | 18.69% |
| 2002-09-27 | 19.10% |
